Cipla Ltd
NSE: CIPLA BSE: 500087
₹1328.90
(0.37)%
Mon, 02 Feb 2026, 01:11 am
Market Cap1069.45B
PE Ratio23.62
Dividend0.98
Health Technology
Pharmaceuticals: Other
24.5KFinancials
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 28.91B | 34.38B | 40.10B | 49.61B | 53.60B | 61.30B | 68.77B | 81.18B | 97.99B | 109.51B | 134.42B | 142.30B | 150.11B | 161.89B | 168.57B | 190.62B | 217.26B | 227.05B | 257.19B | 274.54B |
| Gross profit | 7.02B | 8.04B | 6.10B | 17.34B | 19.75B | 20.04B | 24.65B | 30.02B | 35.41B | 40.67B | 46.43B | 48.24B | 52.77B | 51.89B | 53.96B | 60.76B | 71.94B | 80.46B | 99.37B | 107.84B |
| Operating expenses (excl. COGS) | -1.81B | -2.15B | -1.06B | -9.22B | -10.13B | -11.15B | -11.89B | -12.80B | -20.68B | -28.03B | -28.97B | -33.02B | -35.00B | -32.99B | -34.84B | -28.71B | -35.76B | -39.86B | -45.15B | -46.50B |
| Selling/general/admin expenses, total | — | — | -232.30M | -9.05B | -10.08B | -11.06B | -11.73B | -12.53B | -20.28B | -27.64B | -29.99B | -32.66B | -34.62B | -32.75B | -34.47B | -28.03B | -34.76B | -38.81B | -44.02B | -45.42B |
| Research & development | -1.20B | -1.47B | -232.30M | -2.35B | -2.51B | -2.60B | -2.85B | -328.57M | -4.73B | -6.38B | -7.48B | -8.61B | -8.64B | -3.57B | -3.55B | -1.33B | -2.66B | -3.85B | -4.30B | -3.76B |
| Selling/general/admin expenses, other | — | — | — | -6.69B | -7.57B | -8.47B | -8.87B | -12.20B | -15.55B | -21.26B | -22.50B | -24.06B | -25.98B | -29.18B | -30.93B | -26.70B | -32.10B | -34.96B | -39.71B | -41.66B |
| Other operating expenses, total | -1.81B | -2.15B | -824.00M | -174.30M | -47.40M | -87.60M | -161.60M | -264.50M | -401.90M | -397.20M | 1.02B | -361.10M | -381.10M | -240.10M | -369.80M | -680.60M | -1.00B | -1.05B | -1.13B | -1.08B |
| Operating income | 5.21B | 5.89B | 5.05B | 8.12B | 9.63B | 8.89B | 12.08B | 17.23B | 14.73B | 12.63B | 17.46B | 15.21B | 17.78B | 18.90B | 19.12B | 32.05B | 36.18B | 40.61B | 54.22B | 61.34B |
| Non-operating income, total | 1.85B | 2.16B | 3.27B | 751.20M | 3.63B | 2.73B | 2.40B | 3.73B | 4.07B | 3.91B | -193.40M | -2.94B | -1.00B | 1.89B | 2.66B | 849.00M | -1.24B | -221.70M | 2.80B | 6.87B |
| Interest expense, net of interest capitalized | -114.20M | -69.50M | -117.00M | -522.30M | -229.50M | -173.20M | -383.40M | -339.10M | -1.46B | -1.68B | -2.07B | -1.59B | -1.14B | -1.68B | -1.90B | -1.46B | -911.60M | -755.30M | -785.10M | -517.40M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 1.96B | 2.23B | 3.38B | 1.29B | 3.86B | 2.91B | 2.77B | 4.04B | 5.50B | 5.40B | 1.77B | 3.11B | 4.60B | 5.05B | 3.94B | 2.15B | 1.81B | 3.22B | 4.11B | 4.79B |
| Non-operating interest income | 9.60M | 182.60M | 76.80M | 144.00M | 184.10M | 71.30M | 84.10M | 44.10M | 171.10M | 98.10M | 98.50M | 124.80M | 296.40M | 598.60M | 676.70M | 472.60M | 618.70M | 1.34B | 2.08B | 2.54B |
| Miscellaneous non-operating expense | 1.95B | 2.04B | 3.31B | 1.14B | 3.68B | 2.83B | 2.69B | 4.00B | 5.33B | 5.30B | 1.64B | 2.96B | 4.26B | 4.37B | 3.24B | 1.66B | 1.17B | 1.88B | 2.01B | 2.24B |
| Unusual income/expense | — | — | — | -13.20M | — | — | 11.60M | 25.90M | 26.40M | 191.70M | 107.50M | -4.46B | -4.46B | -1.47B | 615.40M | 160.70M | -2.14B | -2.69B | -524.60M | 2.60B |
| Pretax income | 7.06B | 8.04B | 8.32B | 8.87B | 13.26B | 11.62B | 14.48B | 20.95B | 18.80B | 16.54B | 17.27B | 12.22B | 16.69B | 20.79B | 21.78B | 32.90B | 34.93B | 40.38B | 57.02B | 68.21B |
| Taxes | -980.00M | -1.36B | -1.30B | -1.16B | -2.44B | -1.95B | -3.07B | -5.44B | -4.63B | -4.00B | -3.32B | -1.80B | -2.50B | -5.70B | -6.31B | -8.89B | -9.34B | -12.03B | -15.47B | -15.30B |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -159.30M | -481.50M | -234.30M | -290.30M | -60.40M | 352.60M | 470.00M | 163.60M | -299.00M | -309.80M | -321.70M | 33.20M |
| After tax other income/expense | 0 | 0 | — | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 6.08B | 6.68B | 7.01B | 7.71B | 10.83B | 9.90B | 11.44B | 15.45B | 13.88B | 11.81B | 13.60B | 10.06B | 14.11B | 15.28B | 15.47B | 24.05B | 25.17B | 28.02B | 41.22B | 52.73B |
| Net income | 6.08B | 6.68B | 7.01B | 7.71B | 10.83B | 9.90B | 11.44B | 15.45B | 13.88B | 11.81B | 13.60B | 10.06B | 14.11B | 15.28B | 15.47B | 24.05B | 25.17B | 28.02B | 41.22B | 52.73B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 6.08B | 6.68B | 7.01B | 7.71B | 10.83B | 9.90B | 11.44B | 15.45B | 13.88B | 11.81B | 13.60B | 10.06B | 14.11B | 15.28B | 15.47B | 24.05B | 25.17B | 28.02B | 41.22B | 52.73B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 6.01B | 6.92B | 6.35B | 9.64B | 11.30B | 11.43B | 15.88B | 20.53B | 18.46B | 17.68B | 25.01B | 23.93B | 27.27B | 29.86B | 30.10B | 42.06B | 46.06B | 50.78B | 63.61B | 71.27B |
| EBIT | 5.21B | 5.89B | 5.05B | 8.12B | 9.63B | 8.89B | 12.76B | 17.23B | 14.73B | 12.63B | 17.46B | 15.21B | 17.78B | 18.90B | 19.12B | 32.05B | 36.18B | 40.61B | 54.22B | 61.34B |
| Total operating expenses | -23.70B | -28.49B | -35.06B | -41.49B | -43.97B | -52.41B | -56.01B | -63.96B | -83.26B | -96.87B | -116.96B | -127.09B | -132.34B | -142.99B | -149.45B | -158.57B | -181.08B | -186.44B | -202.98B | -213.20B |
| Prepaid expenses | 1.83B | 2.83B | 3.49B | 2.83B | 12.47B | 14.59B | — | — | — | — | 503.40M | 447.70M | 789.30M | 870.90M | 895.10M | 1.06B | 1.11B | 1.13B | 1.33B | 1.53B |
| Deferred income, current | — | — | — | — | — | — | — | — | 1.07B | 1.06B | 364.70M | 587.30M | 916.70M | 730.00M | 650.10M | 1.69B | 934.50M | 463.70M | 1.35B | 475.40M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 4.80M | 0 | 0 | 0 | 0 | 0 | 1.83B | 1.98B | 1.58B | 2.09B | 2.25B | 2.40B |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 979.50M | 1.13B | 1.49B | 1.64B | 1.79B | 2.13B | 2.34B | 2.82B | 4.11B | 3.87B | 9.76B | 7.57B | 5.03B | 4.25B | 3.65B | 2.97B | 2.44B | 1.63B | 1.85B | 535.30M |
| Deferred income, non-current | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 817.30M | 746.60M | 675.90M | 733.20M | 735.70M | 560.30M | 446.30M | 501.50M | 588.50M | 542.20M |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 495.80M | 1.80B | 3.50B | 4.38B | 3.52B | 3.32B | 2.94B | 2.59B | 2.76B | 3.06B | 959.00M | 958.00M |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | -1.05B | -1.55B | -1.55B | -1.82B | -1.55B | -2.25B | -1.61B | -1.61B | -1.61B | -1.88B | -1.81B | -1.94B | -1.89B | -2.84B | -6.64B | 0 | -4.03B | -4.04B | -6.86B | -10.50B |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800